Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan van Meerbeeck

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Breathe (Sheffield, England)|December 6, 2019
Continuous professional development: elevating thoracic oncology education in EuropeWouter H van Geffen, Torsten G Blum, Stefano Aliberti, et al.
Molecular Oncology|November 14, 2025
Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologiesJanah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, et al.
Plos One|April 1, 2016
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)Jacques De Grève, Jan Van Meerbeeck, Johan F Vansteenkiste, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2012
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesotheliomaJaine K Blayney, Giovanni L Ceresoli, Bruno Castagneto, et al.
Cancer Cell|May 20, 2020
TERAVOLT: Thoracic Cancers International COVID-19 CollaborationJennifer G Whisenant, Annalisa Trama, Valter Torri, et al.
The European Respiratory Journal|May 18, 2023
Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standardDavid R Baldwin, Emma L O'Dowd, Ilona Tietzova, et al.
Journal of Personalized Medicine|January 21, 2022
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in EuropeDenis Horgan, Giuseppe Curigliano, Olaf Rieß, et al.
Diagnosis (Berlin, Germany)|August 1, 2024
Bridging the divide: addressing discrepancies between clinical guidelines, policy guidelines, and biomarker utilizationDenis Horgan, Paul Hofman, Reinhard Buttner, et al.
Cancer Cell|October 22, 2020
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT ExperienceAnnalisa Trama, Claudia Proto, Jennifer G Whisenant, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation studyAbigirl Machingura, Mekdes Taye, Jammbe Musoro, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Breathe (Sheffield, England)|December 6, 2019
Continuous professional development: elevating thoracic oncology education in EuropeWouter H van Geffen, Torsten G Blum, Stefano Aliberti, et al.
Molecular Oncology|November 14, 2025
Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologiesJanah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, et al.
Plos One|April 1, 2016
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)Jacques De Grève, Jan Van Meerbeeck, Johan F Vansteenkiste, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2012
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesotheliomaJaine K Blayney, Giovanni L Ceresoli, Bruno Castagneto, et al.
Cancer Cell|May 20, 2020
TERAVOLT: Thoracic Cancers International COVID-19 CollaborationJennifer G Whisenant, Annalisa Trama, Valter Torri, et al.
The European Respiratory Journal|May 18, 2023
Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standardDavid R Baldwin, Emma L O'Dowd, Ilona Tietzova, et al.
Journal of Personalized Medicine|January 21, 2022
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in EuropeDenis Horgan, Giuseppe Curigliano, Olaf Rieß, et al.
Diagnosis (Berlin, Germany)|August 1, 2024
Bridging the divide: addressing discrepancies between clinical guidelines, policy guidelines, and biomarker utilizationDenis Horgan, Paul Hofman, Reinhard Buttner, et al.
Cancer Cell|October 22, 2020
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT ExperienceAnnalisa Trama, Claudia Proto, Jennifer G Whisenant, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation studyAbigirl Machingura, Mekdes Taye, Jammbe Musoro, et al.
Pageof 6